Literature DB >> 1937819

Nuclease-sensitive binding of an Actinobacillus actinomycetemcomitans leukotoxin to the bacterial cell surface.

H Ohta1, K Kato, S Kokeguchi, H Hara, K Fukui, Y Murayama.   

Abstract

A leukotoxin of Actinobacillus actinomycetemcomitans 301-b was solubilized from cell-associated membrane vesicles by treatment with externally added DNase and RNase and was further purified by a procedure which included ammonium sulfate fractionation, gel filtration chromatography, and ion-exchange chromatography. The purified toxin had a molecular mass of 113,000 Da by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and a high isoelectric point (approximately 8.8). From these characteristics, it was to be expected that the membrane vesicle toxin was almost identical to the leukotoxin extracted with polymyxin B in an earlier study (C.-C. Tsai, B. J. Shenker, J. M. DiRienzo, D. Malamud, and N. S. Taichman, Infect, Immun. 43:700-705, 1984). The treatment with DNase and RNase was also highly effective for solubilizing the leukotoxin directly from whole cells, suggesting that the toxin is secreted extracellularly but retained in nucleic acids on the outermost surface of bacterial cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937819      PMCID: PMC259083          DOI: 10.1128/iai.59.12.4599-4605.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism.

Authors:  C C Tsai; W P McArthur; P C Baehni; B F Hammond; N S Taichman
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  PREPARATION OF TRANSFORMING DEOXYRIBONUCLEIC ACID BY PHENOL TREATMENT.

Authors:  H SAITO; K I MIURA
Journal:  Biochim Biophys Acta       Date:  1963-08-20

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters.

Authors:  B Rotman; B W Papermaster
Journal:  Proc Natl Acad Sci U S A       Date:  1966-01       Impact factor: 11.205

5.  Monoclonal antibodies to leukotoxin of Actinobacillus actinomycetemcomitans.

Authors:  J M DiRienzo; C C Tsai; B J Shenker; N S Taichman; E T Lally
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

6.  Release of toxic microvesicles by Actinobacillus actinomycetemcomitans.

Authors:  A Nowotny; U H Behling; B Hammond; C H Lai; M Listgarten; P H Pham; F Sanavi
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  Generation and release of DNA-binding vesicles by Haemophilus influenzae during induction and loss of competence.

Authors:  R A Deich; L C Hoyer
Journal:  J Bacteriol       Date:  1982-11       Impact factor: 3.490

8.  Transformasomes: specialized membranous structures that protect DNA during Haemophilus transformation.

Authors:  M E Kahn; F Barany; H O Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

9.  Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B.

Authors:  C C Tsai; B J Shenker; J M DiRienzo; D Malamud; N S Taichman
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

10.  Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.

Authors:  A Krishan
Journal:  J Cell Biol       Date:  1975-07       Impact factor: 10.539

View more
  15 in total

1.  Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans.

Authors:  S C Kachlany; D H Fine; D H Figurski
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

2.  TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.

Authors:  Juan A Crosby; Scott C Kachlany
Journal:  Gene       Date:  2006-10-17       Impact factor: 3.688

3.  Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans.

Authors:  Nataliya V Balashova; Juan A Crosby; Lourdes Al Ghofaily; Scott C Kachlany
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 4.  Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.

Authors:  S C Kachlany
Journal:  J Dent Res       Date:  2010-03-03       Impact factor: 6.116

5.  Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.

Authors:  En Hyung Chang; Peter Giaquinto; Joanne Huang; Nataliya V Balashova; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2019-12-26       Impact factor: 3.563

Review 6.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

7.  Association of Actinobacillus actinomycetemcomitans leukotoxin with nucleic acids on the bacterial cell surface.

Authors:  H Ohta; H Hara; K Fukui; H Kurihara; Y Murayama; K Kato
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

Review 8.  Protein selection and export via outer membrane vesicles.

Authors:  K E Bonnington; M J Kuehn
Journal:  Biochim Biophys Acta       Date:  2013-12-24

Review 9.  RTX proteins: a highly diverse family secreted by a common mechanism.

Authors:  Irena Linhartová; Ladislav Bumba; Jiří Mašín; Marek Basler; Radim Osička; Jana Kamanová; Kateřina Procházková; Irena Adkins; Jana Hejnová-Holubová; Lenka Sadílková; Jana Morová; Peter Sebo
Journal:  FEMS Microbiol Rev       Date:  2010-11       Impact factor: 16.408

10.  Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.

Authors:  En Hyung Chang; Angela C Brown
Journal:  J Pharm Pharmacol       Date:  2021-03-08       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.